Health Catalyst Reports Q1 2026 Earnings Beat Despite Revenue Decline
Health Catalyst, Inc. (HCAT) held its first quarter 2026 earnings conference call on May 11, 2026, to discuss financial results for the period ending March 31, 2026. The company reported an earnings per share (EPS) of $0.02, beating analyst estimates by $0.01. Total revenue reached $70.76 million, which surpassed expectations by $1.57 million but represented a 10.90% year-over-year decline. Key executives, including CEO Benjamin Albert and CFO Jason Alger, participated in the call alongside Senior Vice President Stephanie St. Clair. They addressed forward-looking statements regarding future growth, AI initiatives, client migrations, and strategic restructuring efforts. The call featured questions from analysts at major financial institutions such as Wells Fargo, Canaccord Genuity, and Piper Sandler. While the top-line revenue decreased compared to the previous year, the company's ability to exceed both EPS and revenue forecasts indicates resilient operational performance amidst market challenges. The transcript highlights management's focus on maintaining profitability and driving innovation through artificial intelligence while navigating a shifting healthcare technology landscape.
Wire timeline
Health Catalyst Reports Q1 2026 Earnings Beat Despite Revenue Decline
Health Catalyst, Inc. (HCAT) held its first quarter 2026 earnings conference call on May 11, 2026, to discuss financial results for the period ending March 31, 2026. The company reported an earnings per share (EPS) of $0.02, beating analyst estimates by $0.01. Total revenue reached $70.76 million, which surpassed expectations by $1.57 million but represented a 10.90% year-over-year decline. Key executives, including CEO Benjamin Albert and CFO Jason Alger, participated in the call alongside Senior Vice President Stephanie St. Clair. They addressed forward-looking statements regarding future growth, AI initiatives, client migrations, and strategic restructuring efforts. The call featured questions from analysts at major financial institutions such as Wells Fargo, Canaccord Genuity, and Piper Sandler. While the top-line revenue decreased compared to the previous year, the company's ability to exceed both EPS and revenue forecasts indicates resilient operational performance amidst market challenges. The transcript highlights management's focus on maintaining profitability and driving innovation through artificial intelligence while navigating a shifting healthcare technology landscape.
All Articles on Seeking Alpha